Thus, ACresistance in treatment-naïve TNBC can be mediated by nonselective mechanisms that confer a reversible chemotherapy-tolerant state with targetable vulnerabilities.
2
Together, these results demonstrated that tumors can adopt a reversible drug-tolerant state that does not involve clonal selection as an ACresistance mechanism.